The Increasing Prevalence of Respiratory Diseases in the World Is Boosting the Market Growth

 

Respiratory Inhalers Market
Respiratory Inhalers Market

Respiratory Inhalers Market, By Product Type (Dry Powder Inhaler Metered Dose Inhaler Nebulizer (Ultrasonic Nebulizer, Compressed Air Nebulizer, Mesh Nebulizer)), By Technology (Manually Operated Inhaler Devices, Digitally Operated Inhaler Devices), By Disease Indication (Asthma, COPD, Pulmonary Arterial Hypertension, Others), and By Regions (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027.

Market Overview:

Respiratory inhalers are medical devices used to deliver medication directly to the lungs of patients with respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. These devices deliver medication in the form of a mist or spray, which is inhaled by the patient. The medication reaches the lungs directly, providing faster relief and reducing the risk of side effects compared to other forms of medication delivery such as pills or injections. There are several types of respiratory inhalers available, including metered-dose inhalers, dry powder inhalers, and nebulizers.

Competitive Landscape:

Major players operating in the global respiratory inhalers market include Teva Pharmaceutical Industries Ltd., PARI Medical Holding, OMRON Healthcare Europe B.V., Merck & Co., Inc., Koninklijke Philips N.V., GlaxoSmithKline plc., Cipla Ltd., Boehringer Ingelheim GmbH, Beximco Pharmaceuticals Ltd., and AstraZeneca plc.

Key Market Drivers:

The global respiratory inhalers market is expected to be driven by various factors, including the increasing prevalence of respiratory diseases, growing demand for convenient and effective drug delivery systems, and rising adoption of combination therapies for respiratory diseases. For instance, according to the National Institutes of Health (NIH), more than 300 million individuals worldwide are living with asthma

Moreover, the increasing geriatric population and rising healthcare expenditure are estimated to further boost the global respiratory inhalers market growth.

Covid-19 Impact Analysis:

The COVID-19 pandemic has significantly impacted the global respiratory inhalers market. The pandemic has led to an increase in the prevalence of respiratory diseases, leading to a surge in demand for respiratory inhalers. For instance, in July 2020, Teva Respiratory introduced the first digital rescue inhaler called albuterol sulfate 117 mcg rescue inhaler. However, the pandemic has also disrupted the global supply chain, leading to a shortage of raw materials and components needed for the production of respiratory inhalers. Moreover, the pandemic has led to delays in clinical trials and regulatory approvals, further impacting the market growth.

Key Takeaways:

·         North America is expected to dominate the growth of the global respiratory inhalers market, owing to factors such as the high prevalence of respiratory diseases, increasing healthcare expenditure, and the presence of key market players. For instance, according to the Asthma and Allergy Foundation of America, over 26 million individuals in the United States have asthma.

·         The Asia Pacific market is estimated to witness significant growth in the global respiratory inhalers market, owing to factors such as the increasing prevalence of respiratory diseases, rising healthcare expenditure, and growing adoption of combination therapies for respiratory diseases. For instance, according to the National Institutes of Health (NIH), around 30 million individuals have asthma.

Comments

Post a Comment

Popular posts from this blog

Rising Cancer Cases to boost the Molecular Cytogenetics Market Growth

Image
Molecular Cytogenetics Market Molecular Cytogenetics Market by Products (Kits & Reagents, Instruments, and Software & Services), Technique (Fluorescence in Situ Hybridization, Comparative Genomic Hybridization, Karyotyping, Other Techniques), Application (Cancer, Genetic Disorders, Other Applications), And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 – 2030 The global Molecular Cytogenetics Market is estimated to be valued at US$ 4,211.4 million in 2023, and is expected to exhibit a CAGR of 24.5 % over the forecast period, as highlighted in a new report published by Coherent Market Insights. Market Overview: Clinical cytogenetics is the examination of the relation between chromosomal alterations and genetic disorders in human beings. Molecular cytogenetics is an examination of genetic diseases utilizing new techniques and methods that link cytogenetic and molecular t...
Read more

Bispecific Antibodies Are Used As Therapeutic Drugs While Treating Viral Infections, Oncology, And Auto-Immune Diseases

Image
  Bispecific Antibodies Bispecific antibodies are produced through cell fusion or recombinant DNA technologies. Bispecific antibodies are much more specific than monoclonal antibodies. Their applications in tumor immunotherapy are nearly limitless. As of today, seven bispecific antibodies have been approved by the FDA and EMA and over one hundred are in preclinical testing. Bispecific antibodies were initially developed using the quadroma technology. They contain two distinct antigen-binding arms, which enable them to bind to the target antigen while also activating an effector cell, which kills tumor cells. The primary antigen on the surface of the effector cell is called CD3, which is a popular target of immune cells. According to Coherent Market insights the Bispecific Antibodies Market Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028. Many of these multi specific antibody formats have been developed over the past 30 years. These categories ...
Read more

Organic Milk Has Much Higher Concentration Of Iron, Vitamin E, And Polyunsaturated Fatty Acids Omega-3 And Omega-6 As Compared To Regular Milk

Image
  Organic Milk Organic Milk is milk made from livestock raised using organic farming practices. The use of the term "organic" is regulated by food authorities in most jurisdictions. Organic cows are not allowed to be given hormones, which stimulate milk production. Organic feed also must be grown without the use of synthetic pesticides. Organic cows must get a certain percentage of their diet from grazing, although most organic dairies supplement the grass with grain. However, organic grazing cows produce less milk than cows that eat a grain-based diet. Buying organic milk may be a better investment for your health. According to Coherent Market Insights the Organic Milk Market Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028. The standards for organic milk are stringent. To meet the organic standard, a dairy farm cannot use any form of animal growth hormones or antibiotics. Organic cows must spend at least 30% of their lives on pasture. C...
Read more